GPCRs represent the largest human membrane protein family and play a critical role in essential physiological and pathological processes.

With roughly a third of marketed drugs targeting GPCRs, the druggability of this family of receptors is unmatched. But despite this, their implication and drug discovery potential in oncology and immuno-oncology is relatively new.

Chaired by IRIC CEO Michel Bouvier, this virtual symposium will showcase some of the latest discoveries and techniques leveraging the potential of GPCRs in these crucial fields.

Leading experts will share findings from world-class academic and private research on GPCRs in oncology and Immuno-oncology.

And as well as taking part in live Q&As after each presentation, you will have the chance to discuss topics and network with speakers near the end of the symposium.